The new study tests the effectiveness of 14 mg doses against 25 mg and 50 mg formulations
Structurally, semaglutide is a modified peptide analog of human GLP-1, designed to resist enzymatic degradation and prolong its biological half-life, allowing for once-weekly subcutaneous injection
& Silverman, R
Unlike semaglutide, which activates only the GLP-1 receptor, or tirzepatide, which targets both GLP-1 and GIP, retatrutide engages three key metabolic receptors simultaneously: GLP-1 receptor curbs appetite, slows gastric emptying, and lowers blood sugar
Your provider mentions retatrutide as the next-generation GLP-1 drug, and you want to know how it stacks up against the tirzepatide prescription already in your fridge
This mechanism helps prevent hypoglycemia